GlassScriptPhysician profile
Hemant Godara
NPI 1417184029
$6,824.12
in general payments reported to CMS, 2019-2025
20 companies · $694 in 2025
The $694 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,177 · 2020: $410 · 2021: $844 · 2022: $456 · 2023: $673 · 2024: $571 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,339.84 | 2019-2025 | Amplatzer Amulet, Quartet, Aveir |
| Medical Device Business Services, INC. | $1,234.31 | 2019 | |
| Boston Scientific Corporation | $1,216.92 | 2019-2024 | Watchman Access System |
| Biosense Webster, INC. | $852.66 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Medtronic Vascular, INC. | $702.21 | 2019-2020 | |
| Medtronic, INC. | $554.40 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Omniasecure Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $277.63 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $162.04 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $129.81 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia |
| Atricure, INC. | $94.71 | 2019 | |
| Shockwave Medical, INC | $54.20 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $43.35 | 2022-2023 | Repatha |
| Cordis US Corp. | $31.79 | 2025 | Mynx Control Venous |
| Altathera Pharmaceuticals LLC | $24.50 | 2024 | Sotalol Hydrochloride |
| Livanova USA, INC. | $24.30 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.37 | 2023 | Jardiance |
| Siemens Medical Solutions USA, INC. | $18.27 | 2023 | |
| Cardiovascular Systems INC. | $13.46 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.25 | 2019 | |
| Pfizer INC. | $13.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemant Godara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.